Article
Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy
medRxiv · 2022 · Cora C. Hart
Key facts
| Title | Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy |
|---|---|
| First author | Cora C. Hart |
| Journal | medRxiv |
| Published | Oct 5, 2022 |
| DOI | 10.1101/2022.10.02.510519 |
| Devices mentioned | BK110039, K042152, K810863, K940422, K982100 |
| Product codes mentioned | CFN, DBM, DFZ, PCA, NJT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1